Cover Image
市場調查報告書

藥物檢驗:各種技術和全球市場

Drug Testing: Technologies and Global Markets

出版商 BCC Research 商品編碼 325569
出版日期 內容資訊 英文 135 Pages
訂單完成後即時交付
價格
Back to Top
藥物檢驗:各種技術和全球市場 Drug Testing: Technologies and Global Markets
出版日期: 2017年05月25日 內容資訊: 英文 135 Pages
簡介

全球藥物檢驗的市場預計從2016年到2021年以4.5%的年複合成長率發展,預計從2016年的約30億美元,成長到2021年的31億美元的規模。

本報告提供全球藥物檢驗的市場調查,市場及技術概要,主要國家的藥物相關法律,國際的藥物秘密出售、濫用趨勢,各樣品類型的市場規模的變化與預測,產業結構,競爭環境,以及主要企業的簡介等彙整。

第1章 簡介

第3章 市場及技術的背景

  • 單一參數 vs 多參數
  • DOA篩檢
  • 確認檢驗
  • 尿液檢查
  • 其他檢驗法
    • 血液檢驗
    • 口腔液檢驗
    • 唾液檢驗
    • 汗檢驗
    • 毛髮檢驗
  • 檢驗地方
    • 實驗室為基礎的DAT
    • POC DAT
  • 現場檢驗 vs 實驗室檢驗
  • 實驗室檢驗的樣品類型
    • 尿液檢查
    • 毛髮檢驗
    • 口腔液/唾液檢驗
    • 血液檢驗
    • 汗檢驗
    • 眼反射
  • 檢測時間
  • 藥物檢驗的偽裝
  • 樣品的有效性檢驗
  • 假陽性、假陰性
  • 檢驗技術
  • 免疫檢測
    • EIA
    • ELISA
    • EMIT
    • FPIA
    • RIA
    • 層析法
    • 眼反射檢測

第4章 藥物相關法律:各主要國家

第5章 市場概要

  • 藥物濫用檢測
  • 國際的藥物秘密出售、濫用趨勢:各藥物類型
    • 安非他命系興奮劑
    • 大麻
    • 古柯/古柯鹼
    • 鴉片/海洛因
  • 國際的藥物秘密出售、濫用趨勢:各地區

第6章 全球藥物濫用檢測市場:各樣品類型

  • 藥物濫用檢測:銷售額
    • 尿
    • 血液
    • 口腔液
    • 毛髮
    • 其他

第7章 產業結構

  • 地區分析
  • 整體市場預測:藥物濫用檢測、藥物監測
    • 成長趨勢:實驗室檢驗、現場檢驗
  • 競爭分析
    • 主要企業

第8章 專利分析

第9章 企業簡介

BCC 關於Research

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: PHM013G

Report Highlights

The global drug of abuse (DOA) testing market reached nearly $3.0 billion in 2016. This market is estimated to grow at a compound annual growth rate (CAGR) of 4.5% to reach nearly $3.9 billion by 2022 from $3.1 billion in 2017.

Report Includes:

  • An overview of the global market for drug testing technologies.
  • Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
  • An overview of drug abuse trends in terms of various geographic regions as well as drug classes.
  • Information on leading players in the market and their key products.
  • Analysis of leading companies in the field and their successful strategies.

Report Scope

This report contains:

  • An overview of drug abuse trends in terms of various geographic regions as well as drug classes.
  • Drug abuse statistics in key regions.
  • Analysis of regulatory environments in North, South and Central America, Europe, and Asia-Pacific, and country-wise summaries of national legislation and policies.
  • Drug of abuse testing markets with respect to testing approaches and sample matrices.
  • Technology trends in the drug of abuse testing market.
  • Leading players in the market and their key products.
  • Sales projections through 2022 for drug of abuse testing markets by sample matrix and geographic regions.
  • Analysis of leading companies and their successful strategies.

Analyst Credentials

Jon Evans has been involved in business development and research for the medical industry since 1984. Evans' career includes four years as a diagnostic systems sales representative and more than 15 years in market research and strategy analysis with Fortune 500 clients. He has developed expertise in assessing the unique business development challenges facing firms in the medical industry and designing strategies to optimize market performance. Mr. Evans received a B.S. in biology from Rutgers University in 1983, and an MBA in business analysis from San Francisco State University in 1989.

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing the Study
  • Intended Audience
  • Scope of Report
  • Methodology
  • Information Sources
  • Geographic Breakdown
  • Analyst's Credentials
  • Related BCC Research Reports
  • Executive Summary

Chapter 3: Market and Technology Background

  • Single- Vs. Multi-Parameter Test
  • DOA Screening
  • Confirmation Testing
  • Urine Tests
  • Other Testing Methods
    • Blood Testing
    • Oral Fluid Testing
    • Saliva Testing
    • Sweat Testing
    • Hair Testing
  • Testing Locations
    • Laboratory-Based DAT
  • Point of Care DATS
  • Onsite Testing Vs Laboratory Testing
  • Sample Types for Laboratory Testing
    • Urine Testing
    • Hair Testing
    • Saliva/Oral Fluid Testing
    • Blood Testing
    • Sweat Testing
    • Eye Reflex
  • Detection Period
  • Fooling a Drug Test
    • Fooling Urine Testing
    • Fooling Hair Testing
    • Fooling Saliva Testing
  • Sample Validity Tests
  • False Positives and False Negatives
    • False Positives
    • False Negatives
    • Drug Clearance and Testing Window
  • Testing Technologies
    • Immunoassays
    • Enzyme Immunoassay (EIA)
    • Enzyme-Linked Immunosorbent Assay (ELISA)
    • Enzyme Multiplied Immunoassay Technology (EMIT)
    • Fluorescence Polarization Immunoassay (FPIA)
    • Radioimmunoassay (RIA)
    • Chromatography
    • Eye Reflex Measurements

Chapter 4: Government Regulations: Drug Trafficking and Drug Abuse Testing

  • North America
    • Canada
    • Mexico
    • U.S.
    • State Marijuana Legalization
    • U.S. Department of Transportation
    • Drug Testing in the Military
    • Drug Testing for Welfare Recipients and Public Assistance
    • Drug Testing for Individuals Convicted of Drug Felonies
  • South America
    • Bolivia
    • Brazil
    • Colombia
    • Ecuador
    • Guyana
    • Paraguay
    • Peru
  • Central America and the Caribbean
    • Costa Rica
    • Cuba
    • El Salvador
    • Guatemala
    • Haiti
    • Jamaica
    • Nicaragua
    • Panama
    • Honduras
    • The Bahamas
    • The Netherlands Antilles
    • Trinidad and Tobago
  • Europe
    • Bosnia and Herzegovina
    • Denmark
    • France
    • Germany
    • Italy
    • Latvia
    • Norway
    • Romania
    • Sweden
    • Switzerland
    • The Netherlands
    • The United Kingdom
  • Asia-Pacific
    • Australia
    • Bangladesh
    • Bhutan
    • Cambodia
    • Hong Kong
    • India
    • Japan
    • Maldives
    • Myanmar
    • Nepal
    • New Zealand
    • Singapore
    • South Korea
    • Sri Lanka
    • Taiwan
    • Thailand
    • Vietnam

Chapter 5: Overview of Drug Abuse Testing

  • Drug Abuse Testing
  • International Drug Trafficking and Illicit Drug Use Trends by Drug Type
    • Amphetamine-Type Stimulants Market
    • Cannabis Market
    • Coca/Cocaine Market
    • Opium/Heroin Market
  • International Drug Trafficking and Illicit Drug Use Trends by Geographic Region
    • Africa
    • Central America and Caribbean
    • North America
    • South America
    • East and Southeast Asia
    • South Asia
    • West Asia
  • Europe
  • Oceania
  • U.S. DOA Statistics
    • National Household Survey on Drug Abuse: SAMHSA U.S.

Chapter 6: Global Drugs of Abuse Testing Market by Sample Type

  • DOA Testing Sales
  • Global Sales of DOA Testing by Urine
  • Global Sales of DOA Testing by Blood
  • Global Sales of DOA Testing by Oral Fluid
  • Global Sales of DOA Testing by Hair
  • Global Sales of DOA Testing by Sweat
  • Global Sales of DOA Testing by Other Sample Types

Chapter 7: Global Industry Structure

  • Regional Analysis
  • Total DOA Testing and Drug Monitoring Markets and Forecasts
    • Growth Trends-Laboratory-based and Onsite DOA Testing Markets
  • Competitive Analysis
    • Key Market Players in the DOA Testing Markets and Their Products
  • Laboratory-based DOA Testing Market Segment
  • Onsite Testing Market Segment for DOA
  • Common DOA and Most Popular Devices Used for Testing Them
  • Companies in the Oral Fluid, Hair and Sweat Testing Segments for DOA

Chapter 8: Patent Analysis

Chapter 9: Company Profiles

About BCC Research

  • About BCC Research
  • BCC Library Access
  • BCC Custom Research

List of Tables

  • Summary Table: Global DOA Testing Market Forecast, by Test Type, Through 2022 ($ Millions)
    • Table 1: Advantages and Disadvantages of Point of Care Testing
    • Table 2: Major Advantages and Disadvantages of Onsite Testing
    • Table 3: Detection Periods for Various Types of Drug Testing
    • Table 4: Common Parameters Tested for Urine Specimen Validity
    • Table 5: Some of the Commercial/Common Adulterants Used in Fooling Urine Tests and Their Effects
    • Table 6: Urine Sample Validity Test Methods
    • Table 7: Cross Reactants That Can Lead to False Positives in DOA Testing
    • Table 8: Clearance Rates for Common DOA
    • Table 9: U.S. Drug Testing Legislations by State, 2017
    • Table 10: Selected State Marijuana Legalization, 2016
    • Table 11: Drug Testing Legislation by European Country
    • Table 12: Number of Illicit Drug Users Globally, 2015 (Millions)
    • Table 13: Number of Drug-Related Deaths, Mortality Rates per Million Persons Aged 15-64 Years and Ranking of Drugs as Primary Cause of Death (2014 or Latest Year Available), 2016
    • Table 14: Estimated Number of Drug-Related Deaths and Mortality Rates per Million Persons Aged 15-64 Years, 2014
    • Table 15: Annual Prevalence by Region, 2016
    • Table 16: U.S. DOA Seizures, 2014
    • Table 17: Annual Prevalence of Opioid Use as a Percentage of the Population Aged 15-64, 2015 (%)
    • Table 18: Annual Prevalence of Cocaine Use as a Percentage of the Population Aged 15-64, 2015 (%)
    • Table 19: Annual Prevalence of Cannabis Use as a Percentage of the Population Aged 15-64, 2015 (%)
    • Table 20: Annual Prevalence of ATS Use as a Percentage of the Population Aged 15-64, 2015 (%)
    • Table 21: Annual Prevalence of Ecstasy Use as a Percentage of the Population Aged 15-64, 2015 (%)
    • Table 22: Drug Abuse Statistics in the U.S. by Drug Type (12 Yrs and Older), 2014 and 2015 (Thousands)
    • Table 23: U.S. Types of Illicit Drug Use in Lifetime, Past Year, and Past Month Among Persons Aged 18 or Older: Percentages, 2014 and 2015 (%)
    • Table 24: U.S. Illicit Drug Use in Lifetime, Past Year, and Past Month, by Detailed Age Category: Percentages, 2014 and 2015 (%)
    • Table 25: U.S. Marijuana Use in Lifetime, Past Year, and Past Month, by Detailed Age Category: Percentages, 2014 and 2015 (%)
    • Table 26: Global Sales Contribution for DOA Testing, by Sample Type, Through 2022 (%)
    • Table 27: Global Sales Forecast for DOA Testing, by Sample Type, Through 2022 ($ Millions)
    • Table 28: Global Sales Forecast for DOA Testing by Urine, Through 2022 ($ Millions)
    • Table 29: Global Sales Forecast for DOA Testing by Urine: Laboratory-based versus Onsite, through 2022 ($ Millions)
    • Table 30: Global Sales Forecast for DOA Testing, by Blood, Through 2022 ($ Millions)
    • Table 31: Global Sales Forecast for DOA Testing, by Oral Fluid, Through 2022 ($ Millions)
    • Table 32: Global Sales Forecast for DOA Testing by Oral Fluid: Laboratory-based versus Onsite, Through 2022 ($ Millions)
    • Table 33: Global Sales Forecast for DOA Testing, by Hair, Through 2022 ($ Millions)
    • Table 34: Global Sales Forecast for DOA Testing, by Sweat, Through 2022 ($ Millions)
    • Table 35: Global Sales Forecast for DOA Testing, by Other Sample Types, Through 2022 ($ Millions)
    • Table 36: Global DOA Testing Market Forecast, by Region, Through 2022 ($ Millions)
    • Table 37: DOA Testing Market Forecast for Laboratory-based DOA Testing, Through 2022 ($ Millions)
    • Table 38: DOA Testing Market Forecast for Onsite DOA Testing, Through 2022 ($ Millions)
    • Table 39: Most Notable Mergers and Acquisitions in the DOA Testing Markets, 2000-2016
    • Table 40: Major Companies and Their Products in the DOA Testing Market
    • Table 41: Companies Offering Laboratory-based DOA Testing Products
    • Table 42: Main Onsite DOA Testing Market Players and Their Products
    • Table 43: Common DOA and Popular Urine Drug Screening Products
    • Table 44: Key Market Players Offering DOA Testing Products on Oral Fluid, Hair and Sweat Sample Types
    • Table 45: Selected U.S. Patents Granted for DOA Testing, 2007-2017

List of Figures

  • Summary Figure: Global Drugs of Abuse Testing Market Forecast, by Test Matrix, 2016-2022 ($ Millions)
  • Figure 1: U.S. DOA Seizures, 2014
  • Figure 2: Global Sales Forecast for DOA Testing, by Sample Type, 2016-2022 ($ Millions)
  • Figure 3: Global Sales Forecast for Drugs of Abuse Testing by Urine, 2016-2022 ($ Millions)
  • Figure 4: Global Sales Forecast for Drugs of Abuse Testing by Urine: Laboratory-based versus Onsite, 2016-2022 ($ Millions)
  • Figure 5: Global Sales Forecast for Drugs of Abuse Testing, by Blood, 2016-2022 ($ Millions)
  • Figure 6: Global Sales Forecast for Drugs of Abuse Testing, by Oral Fluid, 2016-2022 ($ Millions)
  • Figure 7: Global Sales Forecast for Drugs of Abuse Testing, by Oral Fluid: Laboratory-based versus Onsite, 2016-2022 ($ Millions)
  • Figure 8: Global Sales Forecast for Drugs of Abuse Testing, by Hair, 2016-2022 ($ Millions)
  • Figure 9: Global Sales Forecast for Drugs of Abuse Testing by Sweat, 2016-2022 ($ Millions)
  • Figure 10: Global Sales Forecast for DOA Testing, by Other Sample Types, 2016-2022 ($ Millions)
  • Figure 11: Drugs of Abuse Testing Markets, by Geographic Region, 2017 (%)
Back to Top